112 related articles for article (PubMed ID: 15296638)
1. High-throughput screening assay for identification of small molecule inhibitors of Aurora2/STK15 kinase.
Sun C; Newbatt Y; Douglas L; Workman P; Aherne W; Linardopoulos S
J Biomol Screen; 2004 Aug; 9(5):391-7. PubMed ID: 15296638
[TBL] [Abstract][Full Text] [Related]
2. Targeting aurora2 kinase in oncogenesis: a structural bioinformatics approach to target validation and rational drug design.
Vankayalapati H; Bearss DJ; Saldanha JW; Muñoz RM; Rojanala S; Von Hoff DD; Mahadevan D
Mol Cancer Ther; 2003 Mar; 2(3):283-94. PubMed ID: 12657723
[TBL] [Abstract][Full Text] [Related]
3. Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkin's lymphoma.
Hamada M; Yakushijin Y; Ohtsuka M; Kakimoto M; Yasukawa M; Fujita S
Br J Haematol; 2003 May; 121(3):439-47. PubMed ID: 12716366
[TBL] [Abstract][Full Text] [Related]
4. Interaction and feedback regulation between STK15/BTAK/Aurora-A kinase and protein phosphatase 1 through mitotic cell division cycle.
Katayama H; Zhou H; Li Q; Tatsuka M; Sen S
J Biol Chem; 2001 Dec; 276(49):46219-24. PubMed ID: 11551964
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype.
Lentini L; Amato A; Schillaci T; Di Leonardo A
BMC Cancer; 2007 Nov; 7():212. PubMed ID: 17999753
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of novel anti-cancer agents targeting aurora kinases.
Mahadevan D; Bearss DJ; Vankayalapati H
Curr Med Chem Anticancer Agents; 2003 Jan; 3(1):25-34. PubMed ID: 12678912
[TBL] [Abstract][Full Text] [Related]
7. Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer.
Hu W; Kavanagh JJ; Deaver M; Johnston DA; Freedman RS; Verschraegen CF; Sen S
Oncol Res; 2005; 15(1):49-57. PubMed ID: 15839305
[TBL] [Abstract][Full Text] [Related]
8. The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1.
Du J; Hannon GJ
Nucleic Acids Res; 2002 Dec; 30(24):5465-75. PubMed ID: 12490715
[TBL] [Abstract][Full Text] [Related]
9. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation.
Zhou H; Kuang J; Zhong L; Kuo WL; Gray JW; Sahin A; Brinkley BR; Sen S
Nat Genet; 1998 Oct; 20(2):189-93. PubMed ID: 9771714
[TBL] [Abstract][Full Text] [Related]
10. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers.
Miyoshi Y; Iwao K; Egawa C; Noguchi S
Int J Cancer; 2001 May; 92(3):370-3. PubMed ID: 11291073
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of serine/threonine kinase-15 (STK15) expression by hypoxia and HIF-1.
Klein A; Flügel D; Kietzmann T
Mol Biol Cell; 2008 Sep; 19(9):3667-75. PubMed ID: 18562694
[TBL] [Abstract][Full Text] [Related]
12. Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function.
Chen SS; Chang PC; Cheng YW; Tang FM; Lin YS
EMBO J; 2002 Sep; 21(17):4491-9. PubMed ID: 12198151
[TBL] [Abstract][Full Text] [Related]
13. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human.
Ewart-Toland A; Briassouli P; de Koning JP; Mao JH; Yuan J; Chan F; MacCarthy-Morrogh L; Ponder BA; Nagase H; Burn J; Ball S; Almeida M; Linardopoulos S; Balmain A
Nat Genet; 2003 Aug; 34(4):403-12. PubMed ID: 12881723
[TBL] [Abstract][Full Text] [Related]
14. Amplification/overexpression of a mitotic kinase gene in human bladder cancer.
Sen S; Zhou H; Zhang RD; Yoon DS; Vakar-Lopez F; Ito S; Jiang F; Johnston D; Grossman HB; Ruifrok AC; Katz RL; Brinkley W; Czerniak B
J Natl Cancer Inst; 2002 Sep; 94(17):1320-9. PubMed ID: 12208897
[TBL] [Abstract][Full Text] [Related]
15. The mitotic serine/threonine kinase Aurora2/AIK is regulated by phosphorylation and degradation.
Walter AO; Seghezzi W; Korver W; Sheung J; Lees E
Oncogene; 2000 Oct; 19(42):4906-16. PubMed ID: 11039908
[TBL] [Abstract][Full Text] [Related]
16. Dynamic association of a tumor amplified kinase, Aurora-A, with the centrosome and mitotic spindle.
Stenoien DL; Sen S; Mancini MA; Brinkley BR
Cell Motil Cytoskeleton; 2003 Jun; 55(2):134-46. PubMed ID: 12740874
[TBL] [Abstract][Full Text] [Related]
17. [Mitotic arrest of gastric cancer cells induced by silencing of STK15 gene].
Lan B; Chen XH; Liu BY; Qu Y; Zhang XQ; Cai Q; Dai QB; Zhang J; Zhu ZG
Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):106-9. PubMed ID: 16630486
[TBL] [Abstract][Full Text] [Related]
18. Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells.
Fraizer GC; Diaz MF; Lee IL; Grossman HB; Sen S
Int J Oncol; 2004 Dec; 25(6):1631-9. PubMed ID: 15547700
[TBL] [Abstract][Full Text] [Related]
19. Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules.
Wu JM; Chen CT; Coumar MS; Lin WH; Chen ZJ; Hsu JT; Peng YH; Shiao HY; Lin WH; Chu CY; Wu JS; Lin CT; Chen CP; Hsueh CC; Chang KY; Kao LP; Huang CY; Chao YS; Wu SY; Hsieh HP; Chi YH
Proc Natl Acad Sci U S A; 2013 May; 110(19):E1779-87. PubMed ID: 23610398
[TBL] [Abstract][Full Text] [Related]
20. PF-03814735, an orally bioavailable small molecule aurora kinase inhibitor for cancer therapy.
Jani JP; Arcari J; Bernardo V; Bhattacharya SK; Briere D; Cohen BD; Coleman K; Christensen JG; Emerson EO; Jakowski A; Hook K; Los G; Moyer JD; Pruimboom-Brees I; Pustilnik L; Rossi AM; Steyn SJ; Su C; Tsaparikos K; Wishka D; Yoon K; Jakubczak JL
Mol Cancer Ther; 2010 Apr; 9(4):883-94. PubMed ID: 20354118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
